Results 111 to 120 of about 14,758 (206)

Safety and Immunogenicity of an rVSV Lassa Fever Vaccine Candidate. [PDF]

N Engl J Med
Malkin E, Zaric M, Kieh M, Baden LR, Fitz-Patrick D, Marini A, Yun H, Hayes P, Bromell R, Ayorinde M, Fernandez N, Varma R, Sigei F, Ward M, Pindolia H, Sewell S, Amini F, Blie J, Wilson B, Faley P, McCullough J, Tokpah F, Wisseh C, Towalid E, Hadawale S, Sayeed E, Hunt D, Keshavarzi N, Barin B, Maljkovic Berry I, Parks CL, Truter SG, Walker K, Vekemans J, Lehrman J, Engelbrecht M, Malherbe M, Laufer D, Philiponis V, Higgs E, Mutua G, Fast PE, Gupta SB, rVSVΔG-LASV-GPC Study Group.   +43 more
europepmc   +1 more source

The global distribution of disease and death [PDF]

, 2005
Salloway, Jeffrey Colman
core   +1 more source

The epidemiology of Lassa fever in Ghana: a study on the 2023 Lassa fever outbreak in Ghana. [PDF]

Front Public Health
Akowuah KA, Ofori MS, Pratt D, Abankwa A, Bonney EY, Enimil N, Odei E, Asigbee TW, Laryea D, Ketorwoley P, Amaning JNDA, Boapea MS, Bour S, Ohene SA, Avevor P, Odoom JK, Asiedu-Bekoe F, Kuma-Aboagye P, Kasolo FC, Abuaku B, Yeboah-Manu D, Bonney JHK.   +21 more
europepmc   +1 more source

A promising therapeutic approach for post-Lassa fever sensorineural hearing loss: a case report. [PDF]

Oxf Med Case Reports
Saka SA, Blackie FF, Oseghale EE, Akhabule M, Eze OJ, Ebhota AD, Oboh JO, Abumen E, Agbonifo M.   +8 more
europepmc   +1 more source

A Review of the Epidemiology of Lassa Fever in Nigeria. [PDF]

Microorganisms
Asogun D, Arogundade B, Unuabonah F, Olugbenro O, Asogun J, Aluede F, Ehichioya D.   +6 more
europepmc   +1 more source

Serosurveillance Identifies an Endemic Hotspot of Lassa Fever in Faranah, Upper Guinea. [PDF]

J Infect Dis
Mariën J, Nuismer SL, Magassouba N, Soropogui B, Günther S, Becker-Ziaja B, Gabriel M, Müller-Kräuter H, Strecker T, Saez AM, Borchert M, Fichet-Calvet E.   +11 more
europepmc   +1 more source

Establishment of a Lassa Fever Specimen Biobank in Nigeria. [PDF]

Am J Trop Med Hyg
Chi HF, Etafo J, Fonkeng F, Olufunke GB, Ireneh R, Abejegah C, Owhin S, Somiari S, Vessière A, Bausch DG, El Idrissi I, Fransman W, Kelly-Cirino C, Agogo E, Emperador DM, Adedosu NA.   +15 more
europepmc   +1 more source

In-silico investigations of bioactive compounds from ginger against Lassa fever virus nucleoprotein. [PDF]

Sci Rep
Eyo AE, Edet UO, Abdalla M, Bassey IU, Al-Shouli S, Mbim E, Alghamdi H, Kurdee Z, Alrukhayes M, Imalele EE, Reuben OE, Nwaokorie F, Meseko C.   +12 more
europepmc   +1 more source

Efficacy, safety, and immunogenicity of Lassa fever vaccines: A living systematic review and landscape analysis of vaccine candidates. [PDF]

PLoS One
Bardach A, Berrueta M, Ciapponi A, Sambade JM, Castellana N, Ballivian J, Brizuela M, Caravario J, Comande D, Couto E, Mazzoni A, Ortega V, Parker EPK, Salva F, Stegelmann K, Schieffelin JS, Xiong X, Stergachis A, Munoz FM, Buekens P.   +19 more
europepmc   +1 more source

CD4+ and CD8+ T cells are not the main driver of Lassa fever pathogenesis in macaques. [PDF]

JCI Insight
Prévost J, Tailor N, Soule G, Audet J, Deschambault Y, Vendramelli R, Prado-Smith J, Tierney K, Azaransky K, Kobasa D, Clancy CS, Feldmann H, Rosenke K, Safronetz D.   +13 more
europepmc   +1 more source